N30 Pharma In Deal With NitroMed
Boulder, Colorado-based N30 Pharma said Monday that it has inked a licensing deal with NitroMed, cover respiratory use of the firm's s-nitrosothiol drug candidate. Financial terms were not disclosed. N30 Pharma is a biopharmaceuticals firm focused on discovery, development, and commercialization of respiratory drugs, used for treating cystic fibrosis, asthma, and chronic obstructive pulmonary disease.
posted on Monday, October 29, 2007
Related companies:
N30 Pharma
Related stories:
> N30 Expands Board
> N30 Pharma Raises $30M
> N30 Pharma Finds $30M More
> N30 Pharma Gets Funding
> Nivalis Sets IPO Range
Techrockies.com Home